Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rabaptin, RAB GTPase binding effector protein 1 is a cytosolic effector that links Rab4/Rab5 GTPases with vesicle coat components (such as gamma-adaptin) to regulate endocytic membrane fusion, vesicle trafficking, recycling of endosomes, and protein complex trafficking through cellular compartments. It acts as a crucial mediator of early endocytosis and is implicated in diseases involving altered vesicular transport, including certain cancers and neurodegenerative disorders. The main gene encoding this protein in humans is RABEP1, and it belongs to the rabaptin protein family[1][3][5][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rabaptin, RAB GTPase binding effector protein 1 (RABEP1).